CERo Therapeutics Unveils Promising Phase 1 Data at ASTCT Meeting
CERo Therapeutics Holdings, Inc., a cellular immunotherapy company based in South San Francisco, has announced a significant presentation of data from its ongoing Phase 1 clinical trial, known as CERTAIN-T.…